Rising prevalence of respiratory diseases, and rising global geriatric population are key factors driving market revenue growth.
Market Size - USD 993.2 Million in 2020, Market Growth - CAGR of 6.3%, Market Trends - Increasing focus of major players on manufacturing portable pneumatic nebulizers and other technologically advanced products to cater to ongoing demand.
The global pneumatic nebulizers market size is expected to reach USD 1,628.0 Million in 2028, and register a CAGR of 6.3% during the forecast period. Rising incidences of respiratory diseases, surging geriatric population susceptible to chronic diseases, constant technological advancements, and spreading awareness regarding benefits of pneumatic nebulizers are some of the major factors expected to drive growth of the global market. For instance, according to the World Health Organization, the global number of geriatric people is expected to rise from 841 Million in 2014 to over 2 billion by 2050. Aged people are more susceptible to respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and sleep apnea.
The nebulizer is a medical device that converts drug into fog and sends it directly to the lungs. These are medical equipment used to treat respiratory conditions such as COPD, cystic fibrosis, and asthma. Ventilated pneumatic and pneumatic respiratory nebulizers are the two types of pneumatic nebulizers available currently.
Some Key Findings From the Report:
For the purpose of this report, the global pneumatic nebulizers market is segmented on the basis of product type, end use, and region:
Product Type Outlook
End Use Outlook
Region Outlook
Reasons to Buy the Report
Market Size - USD 993.2 Million in 2020, Market Growth - CAGR of 6.3%, Market Trends - Increasing focus of major players on manufacturing portable pneumatic nebulizers and other technologically advanced products to cater to ongoing demand.
The global pneumatic nebulizers market size is expected to reach USD 1,628.0 Million in 2028, and register a CAGR of 6.3% during the forecast period. Rising incidences of respiratory diseases, surging geriatric population susceptible to chronic diseases, constant technological advancements, and spreading awareness regarding benefits of pneumatic nebulizers are some of the major factors expected to drive growth of the global market. For instance, according to the World Health Organization, the global number of geriatric people is expected to rise from 841 Million in 2014 to over 2 billion by 2050. Aged people are more susceptible to respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and sleep apnea.
The nebulizer is a medical device that converts drug into fog and sends it directly to the lungs. These are medical equipment used to treat respiratory conditions such as COPD, cystic fibrosis, and asthma. Ventilated pneumatic and pneumatic respiratory nebulizers are the two types of pneumatic nebulizers available currently.
Some Key Findings From the Report:
- Among the product type segments, the pneumatic nebulizers segment dominated in the global market over the forecast period.
- Among the end-use segments, the hospitals segment accounted for the largest revenue share of 43.8% in 2020, and is expected to dominate in the global market over the forecast period.
- The Asia Pacific market dominated in the global market over the forecast period, and market size was USD 248.3 Million in 2020, due to rising number of respiratory disorders and surgeries in countries in the region.
- Key players profiled in the report include Aerogen Limited, Allied Healthcare Products Inc., Briggs Healthcare, Becton Dickinson and Company, Heyer Medical AG, OMRON Corporation, PARI Medical Holdings GmbH, Philips Respironics Inc., Salter Labs, and TaiDoc Technologies. The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.
For the purpose of this report, the global pneumatic nebulizers market is segmented on the basis of product type, end use, and region:
Product Type Outlook
- Ultrasonic Nebulizers
- Pneumatic Nebulizers
- Mesh Nebulizers
End Use Outlook
- Hospitals
- Clinics
- Ambulatory Surgical Center
- Home Care
Region Outlook
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
Reasons to Buy the Report
- A robust analysis and estimation of the Pneumatic Nebulizers Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
- A holistic competitive landscape of the all the major players in the Pneumatic Nebulizers Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
- Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
- Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
- Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Table of Contents
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 3. Indicative Metrics
Chapter 4. Pneumatic Nebulizers Segmentation & Impact Analysis
Chapter 5. Pneumatic Nebulizers Market By Product Type Insights & Trends
Chapter 6. Pneumatic Nebulizers Market By End Users Insights & Trends
Chapter 7. Pneumatic Nebulizers Market Regional Outlook
Chapter 8. Competitive Landscape
Chapter 9. Company Profiles
